OA04 Efficacy and safety of nipocalimab in patients with moderate to severe active rheumatoid arthritis: the multicenter, randomised, double-blinded, placebo-controlled phase 2a IRIS-RA study

Taylor, P. C., Schett, G., Ibrahim, F., Zhou, B., Leu, J., Liva, S., … Fei, K. (2024). OA04 Efficacy and safety of nipocalimab in patients with moderate to severe active rheumatoid arthritis: the multicenter, randomised, double-blinded, placebo-controlled phase 2a IRIS-RA study. Rheumatology, 63(Supplement_1). https://doi.org/10.1093/rheumatology/keae163.004